Elon Musk:
Exciting to announce our first million dollar award for supporting our petition against activist judges in Wisconsin!

Next million dollar award will be announced in 2 days.

🚨 SPECIAL OFFER FOR WISCONSIN REGISTERED VOTERS 🚨

Sign this petition and get $100. Refer a petition signer and get $100.

Scott A. From Green Bay, WI is the first $1 Million spokesperson for signing our Petition In Opposition To Activist Judges.

Stay tuned between now and April 1st for more surprise announcements from Wisconsin.

SIGN: https://petition.theamericapac.org


Offer valid from time of posting through 11:59 PM on 4/1/2025. To be eligible, both the referrer and the petition signer must be registered voters of Wisconsin.

Petition in Opposition to Activist Judges
Judges should interpret laws as written, not rewrite them to fit their personal or political agendas.

By signing below, I'm rejecting the actions of activist judges who impose their own views and demanding a judiciary that respects its role—interpreting, not legislating.

https://petition.theamericapac.org/

https://x.com/elonmusk/status/1905074338161942616

"The Lingering Threat: SARS-CoV-2, Immunosuppression, and the Next Health Crisis"

T-cell research | long COVID effects

The persistence of SARS-CoV-2 in the human body, potentially lasting years in some cases, poses a profound challenge to human health, far beyond a simple respiratory illness. Evidence suggests that the virus can linger, even replicate, in tissues like the colon, driving chronic inflammation and immunosuppression that may fail to clear naturally in those with weakened immune responses.

This cycle—where inflammation suppresses T-cell and NK-cell defenses, allowing viral persistence—could theoretically elevate risks for serious conditions, including cancer, echoing known viral triggers like HPV or hepatitis. The alarming rise of long COVID, affecting 15 million Americans with tangible, non-psychiatric symptoms, alongside anecdotal spikes in young-onset cancers, hints at a brewing crisis, possibly the most significant non-infectious pandemic yet.

Traditional virology’s focus on antibodies over T-cells has delayed recognition of cellular immunity’s critical role in viral clearance, though emerging research and T-cell-based therapies offer hope. While regulatory setbacks slow progress, the path forward lies in harnessing the body’s natural defenses to break this cycle—a daunting but not insurmountable task, blending fear with cautious optimism for a solution.

"BioShield and Breaking Echo Chambers: A Dual Crusade in Science and Media"

a visionary disruptor bridging science and media, driven by a belief in solving interconnected crises—health and discourse—through innovation and transparency. Their BioShield and universal vaccine promise transformative health outcomes, while their LA Times overhaul seeks to revive balanced journalism. Yet, both endeavors face steep resistance: political and corporate gatekeepers in biotech, and a recalcitrant, ideologically uniform newsroom in media. Their story is one of ambition tempered by frustration, with outcomes hinging on their ability to navigate or circumvent systemic opposition. As of March 26, 2025, their efforts remain a work in progress, with significant potential to influence the next four years if momentum builds.

Project BioShield – Revolutionizing Immunity Amid Dogma and Resistance

Project BioShield represents a bold departure from antibody-based vaccines, harnessing T-cells to protect against COVID-19 and cancer—a concept validated by NCI and early trials, yet marginalized by a scientific establishment the speaker deems dogmatic. Their journey, from Warp Speed hopeful to self-funded pioneer testing in South Africa, showcases resilience and frustration with systemic blind spots. Funded by $3 billion of their own money and proven through self-experimentation, BioShield underscores their commitment to a paradigm shift in immunity. Tied to their media efforts, this narrative paints a picture of a relentless innovator battling resistance on multiple fronts, with potential to reshape health and discourse if barriers relent.

Conflicts, Immunity, and a Call for Enlightenment in Biomedical Innovation

A troubling underbelly of U.S. biomedical innovation—conflicts of interest at the FDA and NIH that stifle pioneers like themselves, risking America’s global edge to China’s unchecked rise. Their immune system focus, spotlighting NK cells as a "missing link," drives both their BioShield project and practical health advice, challenging the pharma complex’s narrow lens. With $3 billion personally invested and a platform in the LA Times, they stand at a crossroads: a potential "period of enlightenment" under reformist leadership could validate their decades-long fight, amplifying T-cell solutions and reasserting U.S. leadership. Absent such change, their warnings of corruption and decline may prove prophetic, with BioShield remaining a sidelined testament to what could have been.

"BioShield Blocked: A Tale of FDA Resistance and Deep State Motives"

Patrick’s account reveals a frustrating clash with regulatory and political forces that he believes stifled BioShield’s potential to address COVID. His initial FDA approval from Peter Marks and subsequent shutdown highlight a perceived inconsistency, which he ties to a “deep state” influence exemplified by Francis Collins. This experience has solidified his skepticism of public health leadership, framing it as driven by motives darker than patient welfare. His support for Bobby Kennedy and a reimagined FDA reflects a belief that systemic change is both necessary and imminent, fueled by a national awakening in the recent election. Patrick’s narrative is a call to action against entrenched power, urging a shift toward transparency and innovation in healthcare.

Motives darker than patient welfare

"Ego and Emails: Francis Collins’ Campaign to Derail a Nomination"

Patrick’s account paints Francis Collins as a gatekeeper of power, willing to undermine competitors like Patrick and Venter to preserve his influence, as evidenced by damning emails. This resistance, driven by ego and greed rather than public good, thwarted Patrick’s potential NIH leadership, revealing a Washington culture that prioritizes politics over progress. The clarification of BioShield as a therapeutic—not a vaccine—underscores his innovative approach, misaligned with conventional categories yet versatile in its potential. This narrative exposes a personal battle against a entrenched figure while highlighting Patrick’s determination to redefine medical solutions, free from the constraints of dogma and bureaucratic sabotage.

"Unpacking the Spike: COVID, Vaccines, and the Cancer Connection"

Patrick’s hypothesis ties the COVID-19 spike protein—whether from infection or vaccination—to an alarming increase in cancers and health issues via a well-established oncogenic framework. The persistence of the virus, its inflammatory effects, and the disabling of immune defenses like natural killer cells and P53 align with known cancer-causing mechanisms, supported by emerging research. This paints a dire picture of a widespread, underrecognized threat affecting billions, explaining his urgent shift to solutions like viral clearance. His analysis challenges mainstream narratives, framing the spike protein as a unifying culprit behind long COVID and rising oncologic risks, demanding immediate scientific and public health action.

"Smoking Out Cancer: A New Role for Radiation and NK Cells"

Patrick’s innovative approach reimagines radiation as a precision instrument in the cancer fight, using low-dose SBRT to reveal tumors rather than eradicate them directly. By pairing this exposure with NK cell activation, he outlines a streamlined, immune-centric algorithm that could outsmart cancer’s evasive biology. This departure from high-dose dogma highlights a potential breakthrough: leveraging technology and immunity in tandem to shift the battle from brute force to strategic precision, offering hope for more effective, less destructive outcomes.

"The Cancer Symphony: Educating Immunity and Questioning mRNA"

Patrick’s vision transforms cancer care into a coordinated immune symphony—exposing tumors, educating T cells, activating NK cells and macrophages, and suppressing suppression—delivering remission without the brutality of traditional methods. His blood-derived, scalable NK and T cell approach could revolutionize treatment access, merging innovation with humanitarian impact. His critique of mRNA vaccines highlights a scientific unease: their spike protein focus may perpetuate a viral game of evolutionary tag, potentially altering human biology in uncharted ways. Framing the virus as a calculated survivor, he underscores the need for rigorous study over blind policy, advocating a shift from reactive vaccination to proactive viral clearance—a call rooted in both hope and caution.

"Engineering Disaster: Gain of Function’s Lasting Echoes"

Patrick’s narrative frames gain-of-function research as a reckless act that unleashed a human-infective virus, compounded by mRNA vaccines that weaponize its most dangerous component—the spike protein. This dual error, born from hubris and evading U.S. prohibitions, has potentially seeded long-term health crises, from rare cancers to neurological damage, with the spike’s persistence haunting even the uninfected. His call to pivot to the nucleocapsid protein reflects a scientist’s plea for sanity amid chaos, highlighting a safer, T-cell-driven immunity over a flawed, spike-centric approach. The unchecked fallout, he suggests, demands accountability and a radical rethink of viral engineering and vaccine design before more suffer.

The Dangers of Gain-of-Function Research and Its Impact on Human Health ❗️
In the realm of science and medicine, decisions are sometimes made that lead to unpredictable and dangerous consequences. One such case is the research known as "Gain of Function," in which viruses that do not naturally infect humans are manipulated to gain the ability to transmit to humans. These viruses are typically specific to certain species and do not naturally transfer to humans. But the question arises: why should we make such a change in the first place?

Gain-of-function research has been banned in many countries due to its inherent dangers. This type of research is considered so hazardous that even contemplating it seems inherently malevolent. The potential consequences of such actions can be catastrophic; for instance, we now see 13-year-old children developing pancreatic cancer—a disease that was previously extremely rare in this age group. How could anyone undertake such actions? And why aren’t those responsible for these actions held accountable and imprisoned?

In the United States, this type of research was banned. However, it appears that this prohibition was circumvented through collaboration with the Wuhan lab in China. This is where we see how a small number of individuals can cause harm to a vast number of people. The details of how this ban was bypassed are a matter for investigators to uncover. But for someone who has spent years working in laboratories and developing cancer drugs—someone who has achieved great success through their scientific endeavors—it is abundantly clear that such research is far too dangerous. You simply cannot control these viruses. In this research, animal viruses are manipulated, and a process called "affinity maturation," which might take millions of years in nature, is carried out in a lab in a short period of time.

During this process, fusion proteins were created, and these proteins were then used to develop a vaccine. Individuals like Barney Graham and Francis Collins played a role in this project and took pride in creating a protein called RBD, which was supposedly "stabilized." But let’s think about this for a moment: this protein is the spearhead that the virus uses to penetrate the body’s cells. Now, we have made this spearhead even more stable and injected it into the body in the form of an mRNA vaccine—like the Pfizer vaccine. This virus, which initially only existed in bats, has now been transmitted to humans due to gain-of-function research. Then, by creating this vaccine, we have enhanced the virus’s spearhead and introduced it into the body, essentially saying, "Here you go, here’s the virus!"

From the perspective of a layperson, this seems utterly insane. Suppose I have never had COVID-19 and received the Pfizer mRNA vaccine three years ago. Is it possible that traces of the COVID virus could still be in my body now? The answer is: probably yes. This is truly bizarre. I know of a real case—though I won’t mention her name—of a senior official at the U.S. Food and Drug Administration (FDA). She only received the vaccine, and within weeks, she experienced brain fog and memory loss. There is clear evidence that sometimes the vaccine itself, and sometimes the virus, is the cause of these issues. But the key point is that these two are not necessarily separate; it all comes down to the spike protein.

The idea of introducing the COVID virus into a body that has not been infected with it is extremely strange. In fact, we have targeted the wrong protein. For years, I have been pleading for the focus to shift from the spike protein to the nucleocapsid protein. This protein is located in the core of the virus and is not the spearhead. If you activate T-cells, they can last for up to 17 years—we know this from previous studies on coronaviruses.

Ultimately, the question arises: why are such risks being taken? Why are we enhancing the protein that the virus uses to invade the body and injecting it as a vaccine? These actions are not only dangerous but can also lead to irreversible consequences. Perhaps it is time to change our approach and, instead of playing with fire, focus on methods that truly benefit human health.

https://t.iss.one/TuckerTonight/6097

"Tipping the Scales: A Quantum Approach to Cancer’s Immune Dance"

Patrick’s quantum oncotherapeutics reframes cancer as a dynamic, immune-driven tug-of-war, where inflammation shifts cells from protectors to enablers, a balance disrupted by modern toxins and misguided therapies. His analogy to quantum entanglement—where a doctor’s actions determine if the “cat” (immune state) lives or dies—offers a bold, conceptual leap, urging medicine to move beyond blunt tools that empower suppressors. By identifying cancer’s growth as a failure to activate killer cells, he challenges decades of unenlightened practice, pointing to a future where precise, real-time immune modulation could halt disease at its source. This paradigm demands a rethink of root causes and treatments, aligning science with the body’s intricate equilibrium.

The Unseen Persistence of Spike Protein Vaccines

"Spike’s Lasting Shadow: Why Clearing the Virus Matters"

Patrick’s analysis casts the spike protein vaccine as a partial victory overshadowed by a critical flaw: its inability to clear the virus, leaving a persistent, inflammatory residue that mirrors infection’s dangers. His T-cell vaccine hints at a missed opportunity for true prevention, while the spike’s lingering presence—backed by recent science—raises alarms about cancer and immune decline, especially in youth. The failure to prioritize clearance, despite known limitations, suggests a strategic misstep by health leaders, amplifying environmental toxins’ toll. This persistence, whether from virus or vaccine, underscores an urgent need to rethink immunity beyond temporary antibody spikes, aiming instead for eradication to halt a slow-burning health crisis.

The Rising Tide of Youth Cancer and Immune Failure

"Turbocharged Threat: Unpacking Cancer’s Youth Surge"

Patrick’s observations signal a disturbing, non-infectious pandemic of aggressive cancers striking unprecedentedly young patients, from 13-year-olds with pancreatic cancer to 30-year-olds with ovarian cancer, defying historical norms. His firsthand experience and reports of “turbocharged” progression underscore a crisis tied to immune dysfunction—where tumors outsmart or suppress the body’s natural defenders. This shift from equilibrium to vulnerability, potentially fueled by environmental or viral triggers, demands a rethink of cancer as an immunology challenge, not just an oncology one. His call for a unified, dynamic approach—melding exposure, activation, and suppression—offers a path forward, but the siloed medical field and unanswered root causes leave this escalating threat perilously unchecked.

BioShield’s Breakthroughs in Cancer Prevention and Treatment

"BioShield’s Promise: Rewriting Cancer’s Rules"

BioShield emerges as a game-changer in Patrick’s account, bridging prevention and cure across daunting cancers and genetic risks like Lynch syndrome, with tangible victories—nine-year remissions in bladder cancer, five-year survival in pancreatic cancer, and beyond. Its outpatient simplicity belies its potency, sidestepping brutal surgeries and defying grim prognoses, as seen in Senator Reed’s defiance of Collins’ skepticism. This therapy’s 2024 approval and ongoing trials signal a shift from reactive oncology to proactive immunology, offering hope where standard care falters. Patrick’s late-breaking alliance with Robert Kennedy Jr. hints at a broader mission to upend convention, positioning BioShield as a beacon for rewriting cancer’s deadly script.

BioShield and the Orchestrated War on Cancer

"Battlefield Immunity: BioShield’s Tumor-Turning Strategy"

Patrick’s vision transforms cancer treatment into a strategic war, where BioShield orchestrates an immune assault by exposing tumors and arming T cells with lasting memory—flipping the enemy into an ally. The 2024 approval and nine-year remissions in bladder cancer patients underscore its promise, sidestepping brutal surgeries with a low-dose, outpatient finesse. His battlefield metaphor highlights a critical need for regulatory agility to match cancer’s complexity, suggesting that victory lies in syncing multiple immune fronts simultaneously. This approach not only saves lives but redefines the tumor as a teachable moment, potentially shifting cancer care from blunt eradication to elegant, body-driven triumph.